Wijburg, Martijn T.
Warnke, Clemens
Killestein, Joep
Wattjes, Mike P.
Funding for this research was provided by:
Gemeinnützige Hertie-Stiftung (HertiP1150063)
Stichting MS Research (14-358e)
Article History
Received: 30 January 2020
Revised: 29 April 2020
Accepted: 30 April 2020
First Online: 8 May 2020
Compliance with ethical standards
:
: MTW does not report any competing interest. CW has received speaking fees (institutional only) or research support from Novartis, Biogen, Roche and Sanofi Genzyme. JK has received consultancy fees from Merck-Serono, Teva, Biogen, Genzyme and Novartis. MPW has received speaker or consultancy fees from Bayer, Biogen, Biologix, Celgene, Genilac, Imcyse, IXICO, Medison, Merck-Serono, Novartis, Sanofi Genzyme, Roche, Teva, UCB Pharma.
: Software application.
: We obtained a waiver from our local institutional review board stating that the requirements of the Medical Research Involving Human Subjects Act did not apply and that official IRB approval was not mandatory. Written informed consent was obtained from all participants for the use of the clinical, laboratory and imaging data for research and teaching purposes.
: Written informed consent was obtained from all participants for the use of the clinical, laboratory and imaging data for research and teaching purposes. Written informed consent was obtained from all participants for publishing the data.